Tin tức & Cập nhật

Chỉ hiển thị Multimedia
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
20 Sep 2022

The presence of erectile dysfunction (ED) does not appear to confer an increased risk of cardiovascular disease (CVD) and mortality in men with diabetes mellitus (DM), with comparable risk of adverse cardiovascular events among users and nonusers of phosphodiesterase-5 inhibitors (PDE5-Is), which are used to manage ED, according to a study.

PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
20 Sep 2022
Does diabetes worsen survival in metastatic breast cancer?
Does diabetes worsen survival in metastatic breast cancer?
19 Sep 2022

Diabetes does not appear to increase mortality in patients with metastatic breast cancer (MBC), but diabetes and hyperglycaemia both contribute to worse overall survival (OS) in a cohort of longer-term survivors, a study has found.

Does diabetes worsen survival in metastatic breast cancer?
19 Sep 2022
COVID-19 lockdown weakens metabolism in people with glucose intolerance
COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022

In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.

COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022
Insulin glargine, degludec yield comparable effects on glycaemic control
Insulin glargine, degludec yield comparable effects on glycaemic control
09 Sep 2022

In patients with of type 2 diabetes (T2D), glargine 300 U/mL (Gla-300) and degludec 100 U/mL (Deg-100) deliver similar improvements in glycaemic control, without increasing weight and hypoglycaemic events over 6 months of treatment, according to data from the retrospective RESTORE-2 NAIVE study.

Insulin glargine, degludec yield comparable effects on glycaemic control
09 Sep 2022
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
09 Sep 2022
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022

Hypertensive patients who work shifts face an increased risk of developing more than two cardiometabolic diseases or cardiometabolic multimorbidity, according to a study.

Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022